iShares U.S. Medical Devices ETF

IHI · ETF

$54.92+$0.05 (+0.09%)TodayMarket closed ·
Prev close $54.87

About IHI

IHI was created on 2006-05-01 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 3648.64m in AUM and 51 holdings. IHI tracks a market-cap-weighted index of manufacturers and distributors of medical devices in the US.

Issuer
iShares
Tracks
DJ US Select / Medical Equipment
Expense ratio
0.37%
Assets under management
$3.48B
Inception
May 1, 2006
Asset class
Equity

IHI key statistics

Market cap
0
Price-earnings ratio
0.00
Average volume
3.27M
Volume
2.50M
Open price
$54.63
High today
$55.17
Low today
$54.52
52 Week high
$64.71
52 Week low
$47.37

iShares U.S. Medical Devices ETF (IHI) at a glance

As of Oct 23, 2026, iShares U.S. Medical Devices ETF (IHI) shares are priced at $54.92, giving the company a market cap of 0 and a price-to-earnings ratio of 0.00.

Today the fund has traded between $54.52 and $55.17. The current price is 0.7% above the day's low and 0.5% below its high.

Volume so far is 2.50M shares, below the average of 3.27M shares a day.

Over the past year iShares U.S. Medical Devices ETF has ranged from $47.37 to $64.71, and now sits 44% of the way up that range.

IHI news

  • Press releasePRNewswire

    Health Care and Crude Led the Week While Tech Lost Its Grip

  • Vandana Singh

    Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026

  • Akanksha Bakshi

    Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy

  • Akanksha Bakshi

    Philips Bets On AI To See Inside Arteries With SpectraWAVE Buy

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.